The primary agenda item for the board meeting is to consider and approve the allotment of 38,71,854 equity shares of the company to the shareholders of Sushodha Institute of Gastroenterology Private Limited (SIGPL). This allotment is proposed to be made on a preferential basis and for consideration other than cash, indicating a share swap arrangement for acquisition purposes.
The disclosure represents a formal regulatory compliance filing with the Bombay Stock Exchange, with the company's Managing Director Kaushal Uttam Shah (DIN: 02175130) serving as the signatory. The document was digitally signed on October 17, 2026, at 17:54:08 IST from Pune.
Financial Impact
The transaction involves the issuance of 38,71,854 equity shares, which will result in dilution of existing shareholding and potential change in capital structure. The exact financial impact and valuation metrics are not quantified in this disclosure.